iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Marksans Pharma consolidated net profit declines 18.10% in the December 2021 quarter

11 Feb 2022 , 02:46 PM

Net profit of Marksans Pharma declined 18.10% to Rs 48.27 crore in the quarter ended December 2021 as against Rs 58.94 crore during the previous quarter ended December 2020. Sales rose 1.19% to Rs 362.63 crore in the quarter ended December 2021 as against Rs 358.36 crore during the previous quarter ended December 2020.

Particulars Quarter Ended
? Dec. 2021 Dec. 2020 % Var.
Sales 362.63 358.36 1
OPM % 15.94 25.41
PBDT 68.91 86.22 -20
PBT 60.35 77.64 -22
NP 48.27 58.94 -18

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.